Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity

Science
Anne-Laure BulteauLuke I Szweda

Abstract

Numerous degenerative disorders are associated with elevated levels of prooxidants and declines in mitochondrial aconitase activity. Deficiency in the mitochondrial iron-binding protein frataxin results in diminished activity of various mitochondrial iron-sulfur proteins including aconitase. We found that aconitase can undergo reversible citrate-dependent modulation in activity in response to pro-oxidants. Frataxin interacted with aconitase in a citrate-dependent fashion, reduced the level of oxidant-induced inactivation, and converted inactive [3Fe-4S]1+ enzyme to the active [4Fe-4S]2+ form of the protein. Thus, frataxin is an iron chaperone protein that protects the aconitase [4Fe-4S]2+ cluster from disassembly and promotes enzyme reactivation.

References

Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·L J YanR S Sohal
May 9, 2000·The Journal of Biological Chemistry·J Vasquez-VivarM C Kennedy
Jul 20, 2000·The Journal of Biological Chemistry·S Dhe-PaganonS E Shoelson
Aug 10, 2000·American Journal of Human Genetics·J AdamecG Isaya
Oct 13, 2000·Human Molecular Genetics·P CavadiniG Isaya
Jun 8, 2001·American Journal of Human Genetics·P I Patel, G Isaya
Feb 2, 2002·Human Molecular Genetics·Patrizia CavadiniGrazia Isaya
Nov 7, 1996·Chemical Reviews·Helmut BeinertC. David Stout
Mar 27, 2002·Methods in Enzymology·Paul R Gardner
May 23, 2002·Biochemistry·Oleksandr GakhGrazia Isaya
Jun 22, 2002·Current Opinion in Genetics & Development·Hélène Puccio, Michel Koenig
Aug 8, 2002·Human Molecular Genetics·Ulrich MühlenhoffRoland Lill
Sep 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Opal S ChenJerry Kaplan
Mar 5, 2003·Journal of the Neurological Sciences·Robert B Wilson
Apr 2, 2003·Human Molecular Genetics·Emmanuel LesuisseAndrew Dancis
May 7, 2003·The Journal of Biological Chemistry·Sungjo ParkGrazia Isaya
May 21, 2003·Biochemistry·Helen NicholGraham N George
Dec 17, 2003·Biochemistry·Anne-Laure BulteauLuke I Szweda
Jan 27, 2004·Journal of Molecular Biology·Dimos BolisPiero Andrea Temussi

❮ Previous
Next ❯

Citations

Jun 21, 2005·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Joseph P SarseroPanos A Ioannou
Apr 11, 2009·Journal of Neurology·Hélène Puccio
Jun 20, 2008·Molecular Genetics and Genomics : MGG·Claire RemaclePatrice P Hamel
Aug 27, 2009·Journal of Neural Transmission·Kurt A Jellinger
May 28, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Therese BoehmBrigitte Sturm
Nov 27, 2009·Hepatology International·Pablo Muriel
Apr 17, 2013·Brain Research·Timothy E RichardsonJames W Simpkins
Jun 7, 2005·Molecular Genetics and Metabolism·Sara L Van DriestMichael J Ackerman
Jun 21, 2006·Biochemistry·Jeremy D CookTimothy L Stemmler
Apr 2, 2005·Nature Reviews. Molecular Cell Biology·Tracey A Rouault, Wing-Hang Tong
Apr 22, 2009·Molecular BioSystems·Valerie HowerSuzy V Torti
Jan 11, 2008·Proceedings of the National Academy of Sciences of the United States of America·Peter R AndersonJohn P Phillips
Sep 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shaojun LongJulius Lukes
Jun 5, 2010·The Journal of Biological Chemistry·Timothy L StemmlerAndrew Dancis
Jan 16, 2010·Journal of Toxicology and Environmental Health. Part a·Christopher J GordonUrmila P Kodavanti
Mar 11, 2008·Antioxidants & Redox Signaling·Elizabeth L MacKenzieYoshiaki Tsuji
Feb 17, 2010·Antioxidants & Redox Signaling·Renata SantosEmmanuel Lesuisse
May 7, 2011·Antioxidants & Redox Signaling·Michael Li-Hsuan HuangDes R Richardson
Jan 8, 2010·Human Molecular Genetics·Ivano CondòRoberto Testi
Apr 24, 2010·Human Molecular Genetics·Stéphane Schmucker, Hélène Puccio
Dec 4, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J M CooperA H V Schapira
May 31, 2008·Science·Haifeng ShiCaroline C Philpott
Aug 23, 2006·Journal of Bacteriology·Alisa W SerioAbraham L Sonenshein
Mar 7, 2008·Microbiology and Molecular Biology Reviews : MMBR·Carla Ayala-CastroF Wayne Outten
Nov 21, 2007·Biochemistry. Biokhimii︠a︡·D B ZorovT G Khrjapenkova
Apr 10, 2007·Annual Review of Neuroscience·Harry T Orr, Huda Y Zoghbi
Jul 6, 2012·Journal of Child Neurology·R Mark Payne, Gregory R Wagner
Nov 23, 2006·Orphanet Journal of Rare Diseases·Francesc Palau, Carmen Espinós
Sep 2, 2011·Biological & Pharmaceutical Bulletin·Michiko Hamada-KanazawaMasaharu Miyake
Jan 30, 2010·PloS One·Pilar Gonzalez-CaboFrancesc Palau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.